441 – 450 of 1730
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Targeting lipid mediators in asthma : time for reappraisal
(
- Contribution to journal › Article
-
Mark
Increased B-cell activating factor, interleukin-6, and interleukin-8 in induced sputum from primary Sjögren's syndrome patients
(
- Contribution to journal › Article
-
Mark
Osteopontin protects against lung injury caused by extracellular histones
(
- Contribution to journal › Article
-
Mark
Survival in the Swedish cohort with alpha-1-antitrypsin deficiency, up to the age of 43-45 years
(
- Contribution to journal › Article
-
Mark
Translating Basic Research into Safe and Effective Cell-based Treatments for Respiratory Diseases
(
- Contribution to journal › Scientific review
-
Mark
Agreement Between Breathlessness Severity and Unpleasantness in People With Chronic Breathlessness : A Longitudinal Clinical Study
(
- Contribution to journal › Article
-
Mark
REgistry-based randomized controlled trial of treatment and Duration and mortality in long-term OXygen therapy (REDOX) study protocol 11 Medical and Health Sciences 1102 Cardiorespiratory Medicine and Haematology
(
- Contribution to journal › Article
-
Mark
Relative and absolute lung function change in a general population aged 60-102 years
(
- Contribution to journal › Article
-
Mark
The REal Life EVidence AssessmeNt Tool (RELEVANT) : Development of a novel quality assurance asset to rate observational comparative effectiveness research studies
(
- Contribution to journal › Article
-
Mark
Quality standards in respiratory real-life effectiveness research : The REal Life EVidence AssessmeNt Tool (RELEVANT): Report from the Respiratory Effectiveness Group - European Academy of Allergy and Clinical Immunology Task Force
(
- Contribution to journal › Article